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ABSTRACT

AL amyloidosis is due to deposition of protein derived from immunoglobulin light chain
fragments. It is a systemic disorder in which deposition of plasma proteins can adversely
affect function of the heart, liver, kidneys, and peripheral nerves. Deposition in the heart
results in a decrease in the amplitude of the electrical activity of the heart and can be an early
clue to the diagnosis.
A 63-year-old male admitted for volume overload was found to have nephrotic range
proteinuria, progressive renal insufficiency (Creatinine 4.0 increased from his baseline 0.9),
and hypoalbuminemia. On exam, he had diffuse anasarca and peripheral neuropathy.
A renal biopsy showed AL amyloidosis, lambda related, involving the glomeruli, interstitium, and arterial walls. Bone marrow biopsy showed 30% plasma cells with lambda light
chain predominance. Serum free light chains were elevated. Lamda was 11.50 mg/dL and
kappa was 5.12 mg/dL. In retrospective review of his chart, an EKG with low voltage and
anterior pseudo-infarct pattern was first apparent on an admission for stroke two years
prior. Echocardiogram showed mild concentric left ventricular hypertrophy. The patient
was started on chemotherapy with Bortezomib.
The differential of a low-voltage EKG includes many common pulmonary and chest wall
(COPD, obesity) as well as pericardial diseases (effusions), but also important rarer infiltrative
diseases including sarcoidosis and amyloidosis. Amyloidosis of the heart can cause progressive irreversible heart failure, but its progress can be altered if identified early. Physicians
should consider amyloidosis when faced with a low-voltage EKG along with systemic symptoms including nephrotic range proteinuria, peripheral neuropathy, hepatosplenomegaly,
and macroglossia.
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1. Introduction

2. Case Description

AL amyloidosis is a rare systemic disease resulting
from tissue accumulation of amyloid fibrils derived
from monoclonal immunoglobulin light chains.
These light chains can deposit in various organs,
resulting in varying clinical presentations of the
disease.
Amyloidosis frequently involves the heart when
amyloid fibrils are deposited in myocardial tissue
resulting in reduced ventricular compliance with
impairment of relaxation[1]. Amyloid fibrils may
also deposit in myocardial vessels and cause local
ischemia and can also cause fibrosis of conduction
tissue, resulting in conduction abnormalities and
arrhythmias[2]. Cardiac amyloidosis (CA) is associated with a variable but generally poor prognosis,
and early recognition may lead to improved
outcomes.
We discuss two particular findings on ECG in our
case, low voltage on limb leads and pseudo-infarct pattern, that can help provide early identification and diagnosis of CA.

A 63-year-old male with a past medical history of
COPD, CVA with residual left-sided weakness, and
hypertension presented with dyspnea on exertion,
lower extremity swelling, abdominal distention, and
weight gain over the course of six months. He was
admitted for anasarca. Initial laboratory evaluation
revealed nephrotic range proteinuria (urine protein
creatinine ratio 5.14), progressive renal insufficiency
(Creatinine 2.5 mg/dL increased from his baseline
0.9 mg/dL), and hypoalbuminemia (albumin 2.0 g/
dL). On exam, he had diffuse anasarca and peripheral
neuropathy. A renal biopsy showed AL amyloidosis,
lambda related, involving the glomeruli, interstitium,
and arterial walls. During this admission, the patient
unfortunately left against medical advice.
He presented to the hospital three months later with
the same complaints of dyspnea on exertion, abdominal
distention, weight gain, and difficulty walking from the
lower extremity swelling. His renal function worsened to
creatinine of 3.4 mg/dL. Serum free light chains revealed
elevated lambda light chains 11.50 mg/dL, elevated kappa
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light chains 5.12 mg/dL, but a normal kappa/lambda
ratio 0.45. Hemoglobin and calcium were within normal
limits at 14.4 g/dL and 8.8 mg/dL. Skeletal x-ray did not
show bone lesions.
Hematology-Oncology was consulted who recommended a bone marrow biopsy. Bone marrow biopsy
showed 30% plasma cells with lambda light chain predominance. A CD 138 immunohistochemical stain
identified plasma cells (see Figure 1). The bone marrow
touch imprints (see Figure 2) identify plasma cells.
Congo red stain was performed and the apple green
birefringence characteristic of amyloid was not identified. FISH analysis was positive for 13q deletion,
monosomy 13, and additional copies of chromosomes
1q and 9. Cytogenetics revealed normal male karyotype.
In retrospective review of his chart, there were signs
of cardiac amyloidosis on his admission for a stroke two
years prior. ECG at that time showed low voltage criteria and an anterior pseudo-infarct pattern with
Q waves in V1, V2, and V3 (see Figure 3).
Echocardiogram showed mild concentric left ventricular hypertrophy. The patient was started on chemotherapy with Bortezomib but after one cycle, decided to go
on home hospice.

3. Discussion
AL amyloidosis is the most frequent form of amyloidosis (70%)[3]. Amyloidosis constitutes a group of
diseases in which misfolding of extracellular protein
generates insoluble, toxic protein aggregates that are
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deposited in tissues in bundles of β-sheet fibrillary
protein[4]. The clinical manifestations of the disease
are extremely variable depending on the organs
involved and the extent of tissue deposition. Three
quarters of the patients have involvement of multiple
organs at presentation with, in order of frequency,
kidneys (46%), heart (30%), liver (9%), gastrointestinal tract (7%), peripheral nervous system (5%), and
soft tissues (3%)[4].
Renal amyloidosis usually manifests as proteinuria,
often resulting in nephrotic syndrome, as seen in our
case. Development of end-stage renal disease is common
[3,5]. Cardiac involvement may lead to cardiomegaly,
congestive heart failure, and different rhythm disturbances. The electrocardiographic findings include low
voltage and, often, a pattern of myocardial infarction.
Echocardiography usually reveals a concentric thickening of the left ventricle [3,5]. Increased myocardial echogenicity with ‘granular sparkling’ appearance is very
specific of the disease[5]. In this patient, there was renal
amyloidosis present with nephrotic range proteinuria,
progressive renal insufficiency, and hypoalbuminemia.
Renal amyloidosis was confirmed with the renal biopsy.
Two years prior to the diagnosis of renal amyloidosis,
low voltage and anterior pseudo-infarct pattern on ECG
were clinical clues for cardiac amyloidosis (CA). Cheng
et al. concluded that the combination of low voltage on
limb leads and pseudo-infarct pattern on ECG has high
specificity and positive predictive value for the diagnosis
of CA[6]. The results of the Cheng et al. study were
similar with previous reports [7–9]. Murtagh et al. [7].

Figure 1. During normal B-cell development, cells acquire expression of CD 138 which is a marker highly specific for terminally
differentiated normal plasma cells. Since CD 138 is a specific surface antigen for plasma cells in the bone marrow, a CD 138
immunohistochemical stain can identify plasma cells as seen in our case.
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Figure 2. Plasma cells are large lymphocytes with a considerable nucleus-to-cytoplasm ratio. They have an eccentric nucleus
with chromatin in a characteristic clock-face arrangement. This plasma cell in our patient is seen from the bone marrow touch
imprints.

Figure 3. EKG shows low voltage criteria in the limb leads. EKG is also significant for anterior pseudo-infarct pattern with
Q waves in anterior leads V1 – V3. These two findings have high specificity and high predictive value for cardiac amyloidosis.

from the Mayo Clinic reported that in 127 patients with
biopsy-proven proven CA, 46% had low voltage and 47%
had pseudo-infarct pattern. Rahman et al. [8]. reported
that the low voltage was in 56% and pseudo-infarct
pattern was in 60% of patients. Austin et al. [9]. reported
that 45 patients with biopsy-proven CA, the low voltage
was seen in 27% of patients.
The aforementioned studies implicate there were
multiple organs involved at the time of our patient’s
diagnosis with renal and cardiac involvement. During
the admission when our patient was diagnosed with

renal amyloidosis, he also complained of numbness
and tingling in his legs. Sensory neuropathy can be
present in AL amyloidosis, usually as a distal to
proximal and symmetric pattern[5]. However, without electromyography and nerve conduction studies,
there cannot be a definitive diagnosis of peripheral
nervous system involvement.
The clinical history of AL amyloidosis is an interesting
illustration of a multi-systemic disease. The prognosis of
amyloidosis is poor with a median survival of 13 months
in untreated patients[10]. Survival of patients with AL
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undergoing autologous stem-cell transplantation is prolonged to 54 months[11]. Prognosis is also dependent on
the number of organs involved and the extent of tissue
deposition. Our patient likely had renal and cardiac
amyloidosis at the time of diagnosis. Our retrospective
chart review revealed the low voltage and anterior
pseudo-infarct pattern on ECG that preceded the diagnosis by two years. When evaluating low voltage, one
must consider that other conditions such as pericardial
disease, pleural effusions, obesity, and anasarca may contribute to the presence of low voltage on the ECG [12–
14]. The combination of low voltage and anterior
pseudo-infarct pattern on ECG, however, have high specificity and positive predictive value for the diagnosis of
CA[1]. Our case highlights the role that electrocardiography can play for early diagnosis and treatment of AL
amyloidosis.
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